Literature DB >> 12187167

Use of SEER-Medicare data for measuring cancer surgery.

Gregory S Cooper1, Beth Virnig, Carrie N Klabunde, Nicola Schussler, Jean Freeman, Joan L Warren.   

Abstract

BACKGROUND: The accuracy and completeness of the SEER-Medicare data for measuring cancer-related therapy have not been extensively evaluated.
OBJECTIVES: To investigate the best method for measuring cancer-related surgery among patients in the SEER-Medicare database.
SUBJECTS: A total of 149,970 incident cases of breast, colorectal, endometrial, lung, pancreatic, and prostate cancer diagnosed between 1991 and 1993.MEASURES The most invasive surgical procedure identified through Medicare's inpatient, physician, and hospital outpatient claims was compared with corresponding data from the SEER files.
RESULTS: Agreement between the SEER and Medicare files was generally highest for resection and radical surgery (eg, kappa 0.70-0.90). While there was less agreement regarding no surgical therapy and biopsy individually, the concordance of the two sources in excluding cancer-directed surgery was high. Compared with inpatient data alone, using the combined inpatient, physician, and outpatient data increased concordance between SEER and Medicare for less invasive procedures.
CONCLUSIONS: The agreement of SEER and Medicare data appears to be good for major surgical procedures and for excluding persons who did not undergo cancer-directed surgery. Both the SEER and the Medicare data captured a small number of surgeries not reported in the other file. Therefore, where possible, using both data sources will enhance identification of surgeries. Because the analysis was performed with linked data, the accuracy of surgical claims in Medicare data alone cannot be assessed.

Entities:  

Mesh:

Year:  2002        PMID: 12187167     DOI: 10.1097/00005650-200208001-00006

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  111 in total

1.  Are Elderly Patients With Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects.

Authors:  Anirban Basu; John L Gore
Journal:  Med Care       Date:  2015-01       Impact factor: 2.983

2.  Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.

Authors:  Christina D Mack; William Carpenter; Anne-Marie Meyer; Hanna Sanoff; Til Stürmer
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

3.  Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

Authors:  Vickie L Shavers; Martin L Brown; Arnold L Potosky; Carrie N Klabunde; W W Davis; Judd W Moul; Angela Fahey
Journal:  J Gen Intern Med       Date:  2004-02       Impact factor: 5.128

4.  Reduction in physician reimbursement and use of hormone therapy in prostate cancer.

Authors:  Sean P Elliott; Stephanie L Jarosek; Timothy J Wilt; Beth A Virnig
Journal:  J Natl Cancer Inst       Date:  2010-12-03       Impact factor: 13.506

5.  Radiotherapy Planning Complexity and Survival after Treatment of Advanced Stage Lung Cancer in the Elderly.

Authors:  Benjamin Goldsmith; Jamie Cesaretti; Juan P Wisnivesky
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

6.  Balancing cardiovascular (CV) and cancer death among patients with small renal masses: modification by CV risk.

Authors:  Hiten D Patel; Max Kates; Phillip M Pierorazio; Mohamad E Allaf
Journal:  BJU Int       Date:  2014-07-27       Impact factor: 5.588

7.  Extent of surgery affects survival for papillary thyroid cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti; Cord Sturgeon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

8.  Assessing Cancer Treatment Information Using Medicare and Hospital Discharge Data among Women with Non-Hodgkin Lymphoma in a Los Angeles County Case-Control Study.

Authors:  Charlie Zhong; Petra Seibold; Chun R Chao; Wendy Cozen; Joo Y Song; Dennis Weisenburger; Leslie Bernstein; Sophia S Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-17       Impact factor: 4.254

9.  Colon Cancer Staging in Vulnerable Older Adults: Adherence to National Guidelines and Impact on Survival.

Authors:  T B Leal; T Holden; L Cavalcante; G O Allen; J R Schumacher; M A Smith; J M Weiss; H B Neuman; N K LoConte
Journal:  Ann Hematol Oncol       Date:  2014

10.  Treatment patterns for prostate cancer: comparison of Medicare claims data to medical record review.

Authors:  Steven T Fleming; Ann S Hamilton; Susan A Sabatino; Gretchen G Kimmick; Xiao-Cheng Wu; Jean B Owen; Bin Huang; Wenke Hwang
Journal:  Med Care       Date:  2014-09       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.